ALTERITY THERAPEUTICS LTD (ATHE) Insider Trading Disclosures
ALTERITY THERAPEUTICS LTD (ATHE) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ATHE
CIK: 1131343
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 06/30
State: C3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers
Auditor SinceSince 6/30/2017 12:00:00 AM
Lead Engagement PartnerGraeme McKenna
Audit LocationMelbourne, Australia
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-09 | 2026-10-31 | FORM 6-K | 0001437749-26-032387 | View SEC Doc Filr Page |
| 6-K | 2026-10-05 | 2026-10-31 | FORM 6-K | 0001437749-26-031946 | View SEC Doc Filr Page |
| 6-K | 2026-09-25 | 2026-09-30 | FORM 6-K | 0001437749-26-031171 | View SEC Doc Filr Page |
| 6-K | 2026-09-23 | 2026-09-30 | FORM 6-K | 0001437749-26-030992 | View SEC Doc Filr Page |
| S-8 | 2026-09-18 | — | FORM S-8 | 0001437749-26-030708 | View SEC Doc Filr Page |
| 6-K | 2026-09-18 | 2026-09-30 | FORM 6-K | 0001437749-26-030702 | View SEC Doc Filr Page |
| 6-K | 2026-09-16 | 2026-09-30 | FORM 6-K | 0001437749-26-030495 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-08-31 | PRIMARY DOCUMENT | 0002127888-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-08-31 | PRIMARY DOCUMENT | 0002130205-26-000002 | View SEC Doc Filr Page |
| 6-K | 2026-09-08 | 2026-09-30 | FORM 6-K | 0001437749-26-029738 | View SEC Doc Filr Page |
| 6-K | 2026-09-08 | 2026-09-30 | FORM 6-K | 0001437749-26-029736 | View SEC Doc Filr Page |
| 6-K | 2026-09-03 | 2026-09-30 | FORM 6-K | 0001437749-26-029550 | View SEC Doc Filr Page |
| 6-K | 2026-09-02 | 2026-09-30 | FORM 6-K | 0001437749-26-029450 | View SEC Doc Filr Page |
| 6-K | 2026-09-02 | 2026-09-30 | FORM 6-K | 0001437749-26-029449 | View SEC Doc Filr Page |
| 6-K | 2026-09-01 | 2026-09-30 | FORM 6-K | 0001437749-26-029360 | View SEC Doc Filr Page |
| 6-K | 2026-08-31 | 2026-08-31 | FORM 6-K | 0001437749-26-029242 | View SEC Doc Filr Page |
| 6-K | 2026-08-31 | 2026-08-31 | FORM 6-K | 0001437749-26-029240 | View SEC Doc Filr Page |
| 20-F | 2026-08-28 | 2026-06-30 | FORM 20-F | 0001437749-26-029135 | View SEC Doc Filr Page |
| 6-K | 2026-08-28 | 2026-08-31 | FORM 6-K | 0001437749-26-029129 | View SEC Doc Filr Page |
| 6-K | 2026-08-28 | 2026-08-31 | FORM 6-K | 0001437749-26-029127 | View SEC Doc Filr Page |
| 6-K | 2026-08-28 | 2026-08-31 | FORM 6-K | 0001437749-26-029124 | View SEC Doc Filr Page |
| 6-K | 2026-08-21 | 2026-08-31 | FORM 6-K | 0001437749-26-028671 | View SEC Doc Filr Page |
| 6-K | 2026-08-17 | 2026-08-31 | FORM 6-K | 0001437749-26-028086 | View SEC Doc Filr Page |
| 6-K | 2026-08-14 | 2026-08-31 | FORM 6-K | 0001437749-26-027814 | View SEC Doc Filr Page |
| 6-K | 2026-08-13 | 2026-08-31 | FORM 6-K | 0001437749-26-027454 | View SEC Doc Filr Page |